Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Phase I testing of Abiogen's OGP drug to begin in Italy

Dec. 12, 2002

Tetracyclic MCH receptor modulators identified by Tularik scientists

Dec. 12, 2002

Novel alphav integrin antagonists and their use in osteoporosis

Dec. 12, 2002

Neurogen synthesizes GLP-1 receptor modulators with utility in diabetes and eating disorders

Dec. 11, 2002

Hormone replacement therapies and statins in hypercholesterolemic postmenopausal women

Dec. 11, 2002

BioSante licenses triple hormone therapy technology

Dec. 11, 2002

Novo Nordisk submits NDA for NN-304

Dec. 10, 2002

Curis licenses PYY patents to Amylin for treatment of metabolic diseases

Dec. 10, 2002

Once-weekly NeoRecormon approved in Europe for cancer-related anemia

Dec. 9, 2002

Solvay acquires exclusive worldwide rights to cetrorelix

Dec. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...